Epithalon vs Pinealon
Which Is Right for You? Complete Comparison (2026)
Epithalon vs Pinealon — two Khavinson pineal peptides compared. AEDG activates telomerase for longevity.
Epithalon vs Pinealon: At a Glance
- ✓Synthetic tetrapeptide (Ala-Glu-Asp-Gly) pineal bioregulator
- ✓Activates telomerase and promotes telomere elongation in somatic cells
- ✓Regulates melatonin secretion and circadian rhythm
- ✓Extended lifespan and delayed tumor incidence in animal models
- ✓Developed by Prof. Khavinson at the St. Petersburg Institute of Bioregulation
- ✓Synthetic tripeptide (Glu-Asp-Arg) — Khavinson bioregulator
- ✓Crosses the blood-brain barrier
- ✓Neuroprotective effects in oxidative stress models
- ✓Supports melatonin synthesis and sleep architecture
- ✓Part of the Russian bioregulatory peptide research tradition
Detailed Comparison
| Feature | Epithalon | Pinealon |
|---|---|---|
| Mechanism | Synthetic tetrapeptide (pineal gland bioregulator) | Synthetic tripeptide (brain bioregulator)Best |
| Dosing | 5-10 mg SC daily for 10-20 day cycles | 10-20 mg orally or SC per day |
| Administration | Subcutaneous injection | Oral or subcutaneous |
| Half-life | Short — rapid degradation (administered in cycles) | Short — typical for small peptides |
| FDA Status | Not FDA-approved — research peptide | Not FDA-approved — research peptide |
| Key Trial | Khavinson VK et al. Bull Exp Biol Med 2003 — telomerase activation | Khavinson VK. Neuroendocrinol Lett 2002 — peptide bioregulation review |
| Side Effects | Injection site irritation; limited side effect data in humans | Limited data; generally considered well-tolerated |
Which Should You Choose?
Epithalon (Epitalon) (synthetic tetrapeptide (pineal gland bioregulator)) and Pinealon (synthetic tripeptide (brain bioregulator)) serve different clinical roles despite both being in the Longevity peptide space. Epithalon (Epitalon) synthetic version of epithalamin that activates telomerase, promotes telomere elongation, and regulates melatonin production from the pineal gland. Pinealon short bioregulatory peptide (glu-asp-arg) that crosses the blood-brain barrier and supports neuroprotection, sleep regulation, and cognitive function.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Making an Informed Choice Between Epithalon and Pinealon
Choosing between Epithalon and Pinealon depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Epithalon and Pinealon is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Epithalon vs Pinealon: Frequently Asked Questions
Epithalon (Epitalon) is a synthetic tetrapeptide (pineal gland bioregulator) while Pinealon is a synthetic tripeptide (brain bioregulator). They differ in mechanism, dosing, and clinical evidence. Your choice should depend on your specific goals and medical history.
Switching should be done under medical supervision. Your prescriber can advise on transition protocols. Track both in Shotlee for comparison data.
Epithalon (Epitalon) works as a synthetic tetrapeptide (pineal gland bioregulator) (5-10 mg SC daily for 10-20 day cycles), while Pinealon is a synthetic tripeptide (brain bioregulator) (10-20 mg orally or SC per day). They have different half-lives (Short — rapid degradation (administered in cycles) vs Short — typical for small peptides), side effect profiles, and levels of clinical evidence.
Yes. Shotlee supports tracking any medication or peptide. You can compare your results across different protocols.
Neither is universally better — the right choice depends on your individual health profile, treatment goals, side effect tolerance, insurance coverage, and prescriber recommendation. Clinical trial data shows efficacy differences in specific populations, but personal response varies. Track your experience with either medication in Shotlee to generate objective comparison data with your healthcare provider.
Switching between these medications should be done under medical supervision. Your prescriber will consider factors including your current response, reason for switching, dose equivalence, and transition timing. Use Shotlee to document your outcomes on the current medication so you have a clear baseline for comparison after switching.
Track Epithalon or Pinealon in Shotlee
Free dose tracking, side effect logging, and outcome comparison for any medication protocol.
